statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	613
RU - Federazione Russa	176
CN - Cina	120
SG - Singapore	107
IT - Italia	51
HK - Hong Kong	49
IE - Irlanda	37
KR - Corea	35
BR - Brasile	32
SE - Svezia	27
FR - Francia	26
VN - Vietnam	26
IN - India	24
DE - Germania	22
FI - Finlandia	17
CH - Svizzera	13
GB - Regno Unito	10
JP - Giappone	10
NL - Olanda	9
CA - Canada	7
AU - Australia	6
JO - Giordania	6
MX - Messico	6
EC - Ecuador	5
TW - Taiwan	5
UA - Ucraina	5
BD - Bangladesh	4
PL - Polonia	4
AR - Argentina	3
ID - Indonesia	3
IQ - Iraq	3
IR - Iran	3
MA - Marocco	3
NO - Norvegia	3
NP - Nepal	3
SK - Slovacchia (Repubblica Slovacca)	3
ZA - Sudafrica	3
AT - Austria	2
BA - Bosnia-Erzegovina	2
DO - Repubblica Dominicana	2
EG - Egitto	2
LT - Lituania	2
PY - Paraguay	2
SA - Arabia Saudita	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
BJ - Benin	1
CG - Congo	1
CZ - Repubblica Ceca	1
ES - Italia	1
GR - Grecia	1
JM - Giamaica	1
KG - Kirghizistan	1
LB - Libano	1
LV - Lettonia	1
MM - Myanmar	1
NG - Nigeria	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
TR - Turchia	1
UZ - Uzbekistan	1
Totale	1.512

Nome	#
Efficacy, Long-term Efficacy and Tolerability of Lacosamide, Stiripentol, Fenfluramine Hydrochloride and Levetiracetam in children, adolescents and young adults with different types of epilepsy	294
Multiple genomic copy number variants associated with periventricular nodular heterotopia indicate extreme genetic heterogeneity	172
Efficacy and Safety of Long-Term Treatment with Stiripentol in Children and Adults with Drug-Resistant Epilepsies: A Retrospective Cohort Study of 196 Patients	157
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009))	144
Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study	140
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals	134
Polygenic burden in focal and generalized epilepsies	132
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17458 subjects	131
Whole exome sequencing in a cohort of 48 trios with neurodevelopmental disorders	115
Fenfluramine treatment for Dravet syndrome: Long term real-world analysis demonstrates safety and reduced health care burden	97
Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study	9
Totale	1.525

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	0	0	0	10	1
2021/2022	47	3	1	0	5	0	5	0	1	12	3	7	10
2022/2023	152	10	28	10	4	0	31	26	9	13	2	6	13
2023/2024	103	1	9	13	4	4	10	7	23	0	10	13	9
2024/2025	634	24	64	38	69	178	103	11	41	19	31	32	24
2025/2026	534	77	81	66	38	71	22	64	20	36	37	22	0
Totale													1.525